134 related articles for article (PubMed ID: 33523715)
1. NCR3LG1 (B7-H6) is a potential prognostic factor for bladder cancer patients.
Zhao L; Lian T; Li J; Wei S; Li H; Li C; Wang H
Biomarkers; 2021 May; 26(3):260-267. PubMed ID: 33523715
[TBL] [Abstract][Full Text] [Related]
2. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
3. B7‑H3 promotes malignant progression of muscle‑invasive bladder cancer.
Xu ZL; Zhang Y; Wang L; Li F; Man HW; Li PF; Shan BE
Oncol Rep; 2018 Nov; 40(5):2722-2733. PubMed ID: 30132557
[TBL] [Abstract][Full Text] [Related]
4. High expression of B7-H6 in human glioma tissues promotes tumor progression.
Jiang T; Wu W; Zhang H; Zhang X; Zhang D; Wang Q; Huang L; Wang Y; Hang C
Oncotarget; 2017 Jun; 8(23):37435-37447. PubMed ID: 28415577
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
Zhou X; Zhang P; Han H; Lei H; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
[TBL] [Abstract][Full Text] [Related]
6. High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Li W; Liu M; Feng Y; Huang YF; Xu YF; Che JP; Wang GC; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2430-40. PubMed ID: 24228105
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-582-5p regulates cell invasion in bladder cancer through targeting Forkhead Box G1.
Zhuang J; Hao J; Bu F; Yin H; Chen W; Guo H
Pathol Res Pract; 2022 Feb; 230():153752. PubMed ID: 34979422
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
9. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
10. The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions.
Huaqi Y; Caipeng Q; Qiang W; Yiqing D; Tao X
Life Sci; 2019 Sep; 232():116614. PubMed ID: 31260682
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.
Bi J; Liu H; Dong W; Xie W; He Q; Cai Z; Huang J; Lin T
Mol Cancer; 2019 Sep; 18(1):133. PubMed ID: 31481066
[TBL] [Abstract][Full Text] [Related]
12. B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas.
Che F; Xie X; Wang L; Su Q; Jia F; Ye Y; Zang L; Wang J; Li H; Quan Y; You C; Yin J; Wang Z; Li G; Du Y; Wang L
Int Immunopharmacol; 2018 Jun; 59():318-327. PubMed ID: 29679856
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
Tang K; Wang C; Chen Z; Xu H; Ye Z
Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression.
Yang C; Yuan W; Yang X; Li P; Wang J; Han J; Tao J; Li P; Yang H; Lv Q; Zhang W
Mol Cancer; 2018 Jan; 17(1):19. PubMed ID: 29386015
[TBL] [Abstract][Full Text] [Related]
15. Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.
Piao XM; Hwang B; Jeong P; Byun YJ; Kang HW; Seo SP; Kim WT; Lee JY; Ha YS; Lee YS; Kim IY; Choi YH; Cha EJ; Moon SK; Yun SJ; Kim WJ
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982770
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma.
Wu F; Wang J; Ke X
Int J Oncol; 2016 Apr; 48(4):1561-70. PubMed ID: 26891663
[TBL] [Abstract][Full Text] [Related]
17. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
Zhang J; Zhou Q; Xie K; Cheng L; Peng S; Xie R; Liu L; Zhang Y; Dong W; Han J; Huang M; Chen Y; Lin T; Huang J; Chen X
J Exp Clin Cancer Res; 2021 Jun; 40(1):203. PubMed ID: 34154613
[TBL] [Abstract][Full Text] [Related]
18. DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis.
Luo Y; He Z; Liu W; Zhou F; Liu T; Wang G
Oxid Med Cell Longev; 2022; 2022():3369858. PubMed ID: 35103094
[TBL] [Abstract][Full Text] [Related]
19. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.
Xu Z; Huang B; Zhang Q; He X; Wei H; Zhang D
J Cell Biochem; 2019 Apr; 120(4):6596-6604. PubMed ID: 30426533
[TBL] [Abstract][Full Text] [Related]
20. HEATR3 involved in the cell proliferation, metastasis and cell cycle development of bladder cancer acts as a tumor suppressor.
Dou X; Ma X; Meng W; Zhang W; Yang S; Niu F; Xiong Y; Jin T
Mol Genet Genomics; 2023 Nov; 298(6):1353-1364. PubMed ID: 37518364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
